The era of precision neuroscience
Drug Discovery World
MARCH 6, 2024
The development of effective new disease-modifying treatments in neurodegenerative and neuropsychiatric disorders has been hindered by their inherent genetic complexity, environmental influences, and clinical variability. This is comparatively easier to accomplish in these diseases because they are relatively monogenic.
64 
Let's personalize your content